Aandeel ARENA PHARMACEUTICALS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Arena Pharmaceuticals, Inc. Nasdaq

Aandelen

US0400471027

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement
Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P TMI Index
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Global BMI Index
Pfizer Completes Acquisition of Arena Pharmaceuticals
Pfizer Completes $6.7 Billion Acquisition of Arena Pharmaceuticals
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Arena Pharmaceuticals, Inc. Announces Board Changes
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Biotechnology Index
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Composite Index
Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc..
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)
ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Arena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Arena Pharmaceuticals Extends Q4 Loss, Reports Higher Revenue
Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Revenue $54,000, vs. Street Est of $0.732M
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Loss $-2.54, vs. Street Est of $-2.23
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ARNA
  4. Koers
  5. Nieuws Arena Pharmaceuticals, Inc.
  6. Andere talen